Back to search
FDAFDA · Food and drugs·Recall number D-1042-2014

Pantaprazole Sodium Delayed Release Tablets , USP 40 mg, 1000 tablets bottle, Rx only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd Parsippany, NJ 07054 USA. NDC: 64679-0434-02.

Published February 5, 2014 · Recall initiated: November 27, 2013

Summary

FDA records drug Class II recall D-1042-2014, published February 5, 2014 and initiated November 27, 2013. Recalling firm: Wockhardt Usa Inc.; Status: Terminated; Reported quantity: 1129 bottles; Lot: Lot: #: DM12286, Expiry: 06/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications; 12 month acid dissolution test results were above upper limit specifications.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Wockhardt Usa Inc.
Distributor
Nationwide including Puerto Rico
Lot
Lot: #: DM12286, Expiry: 06/14.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Pantaprazole Sodium Delayed Release Tablets , USP 40 mg, 1000 tablets bottle, Rx only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd Parsippany, NJ 07054 USA. NDC: 64679-0434-02. recalled?

Yes. FDA published recall D-1042-2014 on February 5, 2014. Reported hazard: Failed Dissolution Specifications; 12 month acid dissolution test results were above upper limit specifications.

What should I do if I have this product?

Voluntary: Firm initiated · Letter